| Sep 10 |
Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care
|
| Sep 6 |
Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
|
| Sep 5 |
Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
|
| Sep 4 |
New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
|
| Aug 27 |
Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
|
| Aug 20 |
Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
|
| Aug 19 |
Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
|
| Aug 15 |
Jaguar Health Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 13 |
Jaguar Health, Inc. (JAGX) Q2 2024 Earnings Call Transcript
|
| Aug 13 |
Earnings summary: Jaguar Health Q2 results miss estimates
|
